We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03787264
Brief Title: Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL (CLL2-BAAG)

First Submitted : December 20, 2018
First Submitted that Met QC Criteria : December 22, 2018
First Posted : December 26, 2018

Last Update Submitted that Met QC Criteria : November 8, 2022
Last Update Posted : November 9, 2022